p67 phox , whereas these enhancements were abolished by the treatment with PKC inhibitors. High TNF-␣ level exposure induces HUVEC apoptosis, as well as a ROS generation increase via the PKC ␤ 2 -dependent activation of NADPH oxidase. Although the PKC ␦ pathway may enhance TNF-␣ -induced HUVEC apoptosis, it does not involve the ROS pathway. Upregulation of expression of NADPH subunits is important in this process, which leads to a new target in antioxidative therapy for vascular disease prevention.
gration, adhesion [2] , proliferation, differentiation and gene expression [3, 4] . Although there are several potential ROS sources in ECs, including NADPH oxidase, xanthine oxidase, mitochondrial electron transport chains, cyclooxygenase and lipoxygenase [5] , NADPH oxidase is the major source.
The phagocytic NADPH oxidase family is comprised of 5 NOX members (NOX1-NOX5) and of 2 DUOX members (DUOX1 and DUOX2) [6] . The phagocyte NADPH oxidase consists of several proteins which are separated from membranes and cytosol. The cytosolic proteins are p47 phox , p67 phox and p40 phox , which interact with each other to form a complex [7, 8] . The membraneassociated components of the NADPH oxidase are a glycosylated 91-kDa protein (NOX2 or gp91 phox ) and a 22-kDa subunit (p22 phox ) which together form the flavorcytochrome b 558 . The NOX2/gp91 phox subunit is the electron transfer chain of the active NADPH oxidase because it has binding sites for FAD, NADPH and two hemes. The activation of phagocytic NADPH oxidase involves subunit protein expression upregulation and the translocation of cytosolic components to membrane parts, in association with cytochrome b 558 [9] . However, NADPH oxidase in nonphagocytic cells, such as ECs and vascular smooth muscle cells, exhibits certain differences in character and active pathway to phagocytic NADPH oxidases [10] . During the nonphagocytic cell resting state, ROS are still continuously produced by NADPH oxidase. Expression and activity of the enzyme complex is markedly upregulated in the vasculature in a large variety of cardiovascular 'high-risk' states, such as hypertension, hypercholesterolemia and coronary heart disease [11, 12] . In these states, the organism produces an abundance of ROS that requires NADPH oxidase as a cofactor, making the latter a therapeutic target to address oxidative stress in cardiovascular diseases.
The protein kinase C (PKC) pathway is involved in preatherosclerosis mechanisms in the context of insulin resistance and endothelial dysfunction in a rat diabetes model [13] . PKC has been characterized as an important activator of vascular NADPH oxidase [14] . In human coronary arteries, elevated ROS production can be markedly reduced by PKC inhibitors [15, 16] , and research has shown that PKC activation plays an important role in TNF-␣ -mediated EC apoptosis [17] . Because nonspecific isoform-selective PKC inhibitors appear to show severe side effects, these inhibitors are likely not acceptable as therapeutic agents [18] . In clinical trials, PKC ␤ 2 isoformselective inhibitors are well tolerated and show certain therapeutic effectiveness in diabetes patients. Furthermore, Byun et al. [19] report that PKC ␦ can active TNF-␣ toxicity and Xia et al. [20] report that PKC ␤ 2 activation plays a critical role in TNF-␣ -induced oxidative stress in ECV304.
It remains unclear which PKC-selective isoform pathway(s) is/are activated in TNF-␣ -induced human umbilical vein endothelial cell (HUVEC) apoptosis, ac tivation and translocation, and which NADPH com ponents are involved in this regulation. This study was designed to investigate the possible mechanisms of enhanced ROS production via the PKC-dependent activation of NADPH oxidase subunits in TNF-␣ -induced HUVEC apoptosis.
Materials and Methods

Materials
Human recombinant TNF-␣ with a specific activity of 2 ! 10 7 IU/mg was purchased from Prospec Inc., Israel. PKC ␤ 2 inhibitor CGP53353 and PKC ␦ inhibitor rottlerin were obtained from Calbiochem (Merck Biosciences, Darmstadt, Germany). NADPH inhibitor apocynin was obtained from Alexis Biochemicals (Enzo Life Sciences, Farmingdale, N.Y., USA) and gp91ds-tat was obtained from the AnaSpec Company (Fremont, Calif., USA). SFM, Medium199 and collagenase I were obtained from GIBCO (Invitrogen, Carlsbad, Calif., USA). EC growth supplement was purchased from Becton-Dickinson (Franklin Lakes, N.J., USA). The annexin V-FITC/PI apoptosis detection kit was purchased from Roche Diagnostics Corporation (Indianapolis, Ind., USA) and the Bender Medsystem Corporation (Vienna, Austria), respectively. Fluorescent probes 2,7 -dichlorodihydrofluorescein diacetate (DCFH-DA) were from AnaSpec and dihydroethidium (DHE) from Sigma. Polyclonal antibodies against p47 phox and the NOX2/ gp91 phox subunit were obtained from Upstate (Millipore Advanced Life Science, Billerica, Mass., USA). Polyclonal antibodies against p67 phox and p22 phox subunits and monoclonal antibodies against BAX and Bcl-2 were obtained from Santa Cruz Biotechnology Inc. (Santa Cruz, Calif., USA). Polyclonal antibodies against PKC ␣ , PKC ␤ 1 and PKC were also purchased from Santa Cruz Biotechnology. Polyclonal antibody against NOX4 was obtained from Abcam Inc. (Cambridge, UK).
Isolation, Culture and Identification of HUVEC HUVEC were isolated from the umbilical cords of normal pregnancies from Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, in accordance with ethical standards following a protocol described previously [21] , with some modifications. The investigation conformed to the principles outlined in the declaration of Helsinki, and the study method was granted by the Ethics Review Board of the Sun Yat-Sen Memorial Hospital. Briefly, cells were digested from the umbilical vein with 0.1% collagenase I (w/v) at 37 ° C for 20 min, after which they were cultured in 0.1% (w/v) gelatin-coated flasks in Medium 199 supplemented with 10% fetal bovine serum, 15 mg/l ECGS, 2 m M glutamine, 100 units/ml penicillin and 100 ug/ml streptomycin in an atmosphere of 5% CO 2 at 37 ° C. The medium was changed every 2-3 days until the ECs reached confluence. Cultured cells were identified as ECs by their morphology and the presence of VIII-related antigen detected using an indirect immunocytochemistry method. The purity of HUVEC in culture was higher than 95% and passages 2-4 were used in the research.
Experiment Conditions
We seeded 2 ! 10 5 cells in the plastic flask. After HUVEC reached 80% confluency, they were transferred to 1% fetal bovine serum SFM and preincubated for 24 h. For 24 h they either remained untreated (control), were treated with 40 ng/ml TNF-␣ alone (TNF-␣ group) or were treated with TNF-␣ plus one of the following: CGP53353 (TNF-␣ +CGP group), rottlerin (TNF-␣ +Rot group), CGP53353+rottlerin (TNF-␣ +CGP+Rot group), gp91ds-tat (TNF-␣ +gp91ds-tat) or apocynin (TNF-␣ +Apo group). The last treatment was incubating TNF-␣ in PKC ␤ 2 knockdown HUVEC. The concentration of TNF-␣ used to induce apoptosis was according to our preliminary dose-finding study and the previous research of others [20, 22] , which demonstrate that 40 ng/ml TNF-␣ could significantly induce EC apoptosis. The choice of concentrations of inhibitors were based on the fact that 10 M rottlerin [23] , 1 m M CGP53353 [24] and 5 ! 10 -6 M gp91ds-tat [25] could inhibit PKC ␦ and PKC ␤ 2 isoforms and NADPH oxidase, respectively. CGP53353 is a much more highly selective inhibitor of PKC ␤ 2 than of other PKC isoforms in ECs [20] .
Hoechst 33342 and Annexin V-FITC/PI Staining DNA chromatin morphology was assessed using Hoechst staining. HUVEC were labeled with 10 g/ml of Hoechst 33342 for 2 min, and cells were then examined by fluorescence microscopy. Annexin V-FITC/PI staining was done as described previously [26] . HUVEC were harvested by centrifugation and washed 3 times with ice-cold PBS. Then 100 l binding buffer, 10 l annexin V-FITC and 5 l PI were added to each tube in a dark room one by one. The emissions of annexin V-FITC/PI were detected in the FL1 and FL2 channels of FACScan flow cytometry (Epics Altra, Beckman Coulter, Fullerton, Calif., USA), using 525-nm and 575-nm filters, respectively. The proportions of viable cells, cells in early apoptosis, late apoptosis and necrosis were calculated using the CellQuest software (Beckman Coulter).
Detection of Intracellular ROS
DCFH-DA, a nonpolar dye that readily diffuses into the cells, allows the monitoring of intracellular ROS production by flow cytometry. This method is based on the oxidation of DCFH-DA by intracellular ROS resulting in the generation of the highly green fluorescent compound 2 ,7 -dichlorofluorescin (DCF), which is polar and trapped within the cells. DHE is oxidized by superoxide and forms red fluorescent ethidium, which can bind to DNA, resulting in amplification of the red fluorescent signal. Special fluorescence production was collected and measured by flow cytometry. After the treatment, HUVEC were incubated with medium containing DCFH-DA (5 M ) or DHE (10 m M ) for 15 min at 37 ° C in the dark, washed twice with PBS, and then collected. Fluorescence signals were obtained by using a band-pass filter at 530 nm for DCF and a band-pass filter at 585 nm for DHE. Each determination was based on a mean fluorescence intensity of 10,000 cells.
Reverse Transcription and Quantitative Real-Time RT-PCR
Total RNA (2.5 g) was extracted from the HUVEC using Trizol reagent according the manufacturer's instructions (Invitrogen). Extracted RNA was then reverse-transcribed to cDNA by AMV transcriptase with random priming. Quantitative real-time RT-PCR was performed using a standard method, as described in the manufacturer's kit instructions by use of a synthetic genespecific primer for the following target genes: NOX2/gp91 phox , NOX4, p22 phox , p47 phox and p67 phox . The process was carried out using a Roche LightCycler 480 in a total volume of 20 l comprising 2 l of 1: 10 diluted first-strand cDNA, 2 l each of the forward and reverse primers (5 M Western Blotting Analysis HUVEC were exposed to various predetermined experimental conditions. Then cells were harvested and lysed for total and membrane protein extraction. Membrane fraction was obtained as follows: HUVEC were washed with ice-cold PBS, lysed in 10 m M Tris-HCl (ph 7.5), 5 m M EDTA and 50 g/ml phenylmethyl sulfonyl fluoride, and ultracentrifuged at 100,000 g for 1 h at 4 ° C, after which supernatant fluids were collected and designated as cytosolic fraction. The remaining pellets were resuspended in the lysis buffer described above, in addition to 1% Triton X-100, sonicated and then incubated for 45 min at 4 ° C. Lysates were then centrifuged at 4 ° C, the supernatant fluids were designated as membrane fraction. Equal amounts of protein (60 g) from the cell lysates were subjected to membrane protein Western blot analysis. Protein concentration was determined using the BCA protein assay. Cytoplasm extractions were obtained using special extraction reagents. For immunoblotting, lysate amounts allowing equal protein loading between lanes were determined and mixed with 5 ! SDS sample buffer, boiled for 5 min and separated by 10-15% SDS/PAGE before transferring the proteins onto nitrocellulose membranes. After blocking in 5% skim milk for 1 h, the membranes were rinsed and incubated overnight at 4 ° C with gentle shaking and with the appropriate diluted primary antibody in 5% BSA, 1 ! Tris-buffered saline (TBS) and 0.1% Tween-20 (TBS/T). Excess antibody was then removed by washing the membranes with TBS/T and subsequent incubation with horseradish peroxidase-conjugated secondary antibody for 1 h at room temperature. After further washes in TBS/T, the bands were visualized using an enhanced chemiluminescence detection kit and radiographic film exposure.
Transfection of PKC ␤ 2 siRNA
Human PKC ␤ 2 and GAPDH-specific siRNA were synthesized (Life Technologies) and used for transfection. The sense and antisense strands of the PKC ␤ 2 siRNA were 5 -GCUGCU-UUGUGGUGCACAATT-3 and 5 -UUGUGCACCACAAA G-CAGCTT-3 . GAPDH siRNA was used as a negative control. HUVEC were transfected using Lipofectamine 2000. HUVEC in transfection reagent (8 l) were added to 100 l Opti-MEM serum-free medium containing 2 n M of each siRNA oligo, incubated for 10 min, and added to the 6-cm plate containing 2 ml of medium. The efficacy of PKC ␤ 2 silencing and reductions in protein expression were assessed after 72 h in the same group of cells by Western blot analysis. Transfected cells were cultured in serum-free medium in the presence or absence of 40 ng/ml TNF-␣ for 24 h.
Statistical Analysis
All results are expressed as means 8 SD. Differences among groups were tested by 1-way analysis of variance (ANOVA) followed by Bonferroni correction for post hoc analysis. A value of p ! 0.05 was considered statistically significant. All of the statistical tests were performed using GraphPad Prism software version 5.0 (GraphPad Software, San Diego, Calif., USA) and SPSS16.0 (SPSS Inc., Chicago, Ill., USA).
Results
Effect of TNF-␣ and PKC Inhibitors on HUVEC Morphology
When cultured ECs reached confluent, they presented a 'cobblestone appearance' ( fig. 1 a) . The cells were identified as ECs by their specific morphology and the presence of VIII-factor-related antigen which showed positive staining ( fig. 1 b) . Three random microscope fields showed that about 95% of the cells presented positive staining reflecting the purity of cultured primary HUVEC. A high proportion of HUVEC treated with 40 ng/ml TNF-␣ for 24 h became slim, then rounded, and detached from the plates or dishes. However, there were lower proportions of rounded and detached cells treated with TNF-␣ plus CGP53353, rottlerin, a combination of CGP+rottlerin, apocynin or gp91ds-tat ( fig. 1 c-i) . We referred to previous research for the inhibitor concentrations [20, 27, 28] .
Changes of Endothelial Cell Apoptosis
To determine whether 40 ng/ml TNF-␣ on HUVEC led to cell apoptosis, EC apoptosis was measured by Hoechst 33342 and annexin V-FITC/PI staining by flow cytometry. Normal HUVEC nuclei were lightly stained by the dye, while the nuclei of TNF-␣ -treated cells presented typical apoptosis features; they were deeply stained, dense, fragmented, and even apoptotic bodies could be seen. Different PKC isoform inhibitors could reduce the apoptotic rate induced by TNF-␣ ( fig. 2 a) . The percentage of apoptosis cells labeled with Hoechst 33342 increased from 1.6 8 0.7% in the control group to 11.1 8 1.1% in the 40 ng/ml TNF-␣ -treated group, while in the CGP53353, rottlerin, CGP53353 + rottlerin, apocynin and gp91ds-tat groups, the proportions of apoptotic cell rate were 4.0 8 1.4, 2.9 8 0.6, 2.3 8 0.1, 2.5 8 1.1 and 2.7 8 0.4%, respectively ( fig. 2 b) . All inhibitors could induce apoptotic rate significantly, especially a combination of two PKC isoform inhibitors. The proportion of apoptotic cells, including the early and late periods, labeled with annexin V-FITC/PI increased from 3.9 8 2.4% in normal control HUVEC to 16.1 8 3.1% in the TNF-␣ -induced apoptosis group, suggesting a more than 4-fold increase in the amount of apoptosis cells. The percentage of apoptotic rate in CGP53353, rottlerin, CGP53353 + rottlerin, apocynin and gp91ds-tat groups in the presence of TNF-␣ were 6.2 8 2.1, 7.2 8 1.1, 4.7 8 0.3, 8.1 8 0.6, 9.1 8 0.3%, respectively ( fig. 2 c, d ). All results suggested that, regardless of the methods used to detect apoptosis, 40 ng/ml TNF-␣ could induce HUVEC apoptosis, and different PKC isoform pharmacological inhibitors inhibit the process effectively. The combination of two PKC isoform inhibitors reduced the apoptotic rate much more effectively than either drug alone. There were significant differences among the groups (p ! 0.05).
Changes of ROS Production
ROS generation was involved in TNF-␣ -induced HUVEC apoptosis. The basal level of intracellular ROS, measured by flow cytometry after DCFH-DA labeling, was about 1081.6 8 27.5 units, reflecting active essential oxidation production in untreated HUVEC. As shown in figure 3 A, the addition of TNF-␣ led to enhanced oxidative stress, and this effect was attenuated in combination with CGP53353, rottlerin or apocynin to different extents. The average DCF-detected ROS fluorescence intensity induced by 40 ng/ml TNF-␣ was 1,651.1 8 74.6, while the mean fluorescence value plus CGP53353 was 1,063.4 8 20.1 and with rottlerin it was 1,393.5 8 100.6. The decrease achieved statistical significance for the CGP53353 group versus the TNF-␣ group; however, there was no statistical significance between the rottlerin and TNF-␣ groups. Therefore PKC ␤ 2 inhibitor, but not PKC ␦ inhibitor, may effectively reduce TNF-␣ -mediated ROS production. DHE-detected ROS proved the same thing in a different treatment group. As shown in figure 3 B, stimulation of HUVEC with TNF-␣ resulted in an increase of DHE fluorescence intensity of about 2.2-fold, compared to the control group. CGP53353, rottlerin and a combination of both attenuated these increases. Rottlerin did not attenuate a TNF-␣ -induced increase of DHE fluorescence intensity more effectively than CGP53353 (p 1 0.05), while DHE fluorescence intensity in the CGP and CGP + Rot groups decreased significantly compared to that of the TNF-␣ group (p ! 0.05).
Changes of Gene Expression
Expression of the NOX2/gp91 phox , NOX4, p22 phox , p47 phox and p67 phox genes changed dramatically in TNF-␣ -induced HUVEC apoptosis. As shown in figure 4 , in the presence of 40 ng/ml TNF-␣ , the expression of NOX2/ gp91 phox gene increased significantly up to 11.4-fold to the control value (each gene expression in the control group was considered as 1 unit). Expression of other genes in the TNF-␣ -treated group varied differently compared to the controls: 1.7-fold for NOX4, 1.5-fold for p22 phox , 3.1-fold for p47 phox and 2.1-fold for p67 phox . All the gene expressions had significant differences compared to the control group (p ! 0.05). Figure 4 clearly showed that under the action of TNF-␣ , the change in the NOX2/gp91 phox gene was more dramatic compared to the other genes studied; p47 phox and p67 phox gene expression also changed more than p22
phox . In addition, CGP53353 and rottlerin affected gene expression differently. However, we could conclude for all the genes investigated that, compared to the apocynin group, rottlerin was not as powerful as CGP53353 in inhibiting NADPH oxidase subunit gene expression. For the NOX2/gp91 phox , NOX4 and p47 phox genes, there were no significant differences between the TNF-␣ and rottlerin groups (p 1 0.05), while for all the genes investigated, there were significant differences in expression levels between the TNF-␣ and CGP53353 groups (p ! 0.05). Compared with rottlerin, CGP53353 could downregulate NOX2/gp91 phox , NOX4 and p47 phox gene expression more obviously.
Changes of Protein Expression
Two apoptosis-related proteins, BAX and Bcl-2 were detected in this research. TNF-␣ obviously increased BAX protein expression, and this effect was inhibited by rottlerin, CGP53353 and apocynin. In addition, TNF-␣ significantly decreased Bcl-2 while the two PKC inhibitors upregulated its expression (p ! 0.05) ( fig. 5 a) .
The NOX2/gp91 phox NADPH oxidase comprises 2 membrane subunits (p22 phox and gp91 phox ) and 3 cytosolic subunits (p47 phox , p67 phox and Rac-2). Upon cytokine, mechanical shear and other stimulation, the cytosolic subunits of NADPH oxidase translocate from cytosol to membrane to induce ROS production. To further describe the effects, we studied expression and translocation of subunits in the presence of TNF-␣ plus CGP53353, rottlerin, CGP53353 + rottlerin or apocynin. TNF-␣ increased expression of NOX2/gp91 phox 4.8-fold and NOX4 2.5-fold (p ! 0.01); it tended to decrease after the addition of PKC inhibitors (p ! 0.01) ( fig. 5 b) . Expression of p22 phox protein also increased to 1.7-fold (p ! 0.05) by TNF-␣ , whereas rottlerin and CGP53353 had no effect on it ( fig. 5 d) . We also found that 40 ng/ml TNF-␣ induced the translocation of p47 phox and p67 phox from cytosol to membrane ( fig. 5 c) . The activation of these NADPH oxidase subunits was prevented by CGP53353, rottlerin or apocynin, with inhibitory effects achieving statistical significance (p ! 0.05). Compared to the TNF-␣ group, the subunit protein level reduced significantly in the combination, CGP53353 or rottlerin groups ( fig. 6 ). The combination of two inhibitors decreased NADPH oxidase subunits much more effectively than either drug alone (p ! 0.05).
Apoptosis of HUVEC Transfected with PKC ␤ 2 siRNA
According to the ROS generation, gene and protein results mentioned above, we chose PKC ␤ 2 as our next study object. To understand whether the PKC ␤ 2 pathway played a more important role in TNF-␣ -induced HUVEC apoptosis, we used siRNA to knock down PKC ␤ 2 expression and then examined the resultant changes in the presence and absence of TNF-␣ . A scrambled siRNA sequence was used as a control. Apoptosis was detected by annexin V-FITC/PI staining by flow cytometry and apoptotic-related proteins BAX and Bcl-2 in transfected HUVEC. As shown in figure 7 a, scrambled siRNA sequence was used as a control. Western blot analysis indicated that the knockdown efficiency was about 65% with this siRNA clone. In figure 7 b, the TNF-␣ -induced apoptotic proportion in cells transfected with PKC ␤ 2 -siRNA was 10.5 8 1.7%, compared with scrambled siRNA 20.1 8 3.1%. Values represent the means 8 SD of 3 independent experiments. There was significance between the two groups (p ! 0.05). As shown in figure 7 c, the PKC-␤ 2 -siRNAtransfected group could downregulate the BAX/Bcl-2 ratio. All the results in figure 6 suggest that HUVEC transfected with PKC ␤ 2 siRNA could efficiently decrease 40 ng/ml TNF-␣ -induced apoptosis. In addition, we detected the other major PKC isoforms, such as PKC ␣ , PKC ␤ 1 and PKC ␦ , to prove that their expression was not affected by the PKC ␤ 2 siRNA that we used ( fig. 8 ).
The Changes of HUVEC Transfected by PKC ␤ 2 siRNA Protein Expression
According to the NADPH oxidase subunit protein changed above ( fig. 5 ) , we chose NOX4, NOX2/gp91 phox , p47 phox , p67 phox as our targets to determine whether cells transfected with PKC ␤ 2 siRNA could achieve the same effect with a PKC ␤ 2 pharmacological inhibitor. In figure 9 a, transfected HUVEC could effectively downregulate NOX4 and NOX2/gp91 phox induced by 40 ng/ml TNF-␣ , with significant differences (p ! 0.05).
We also found that TNF-␣ -induced translocation of p47 phox and p67 phox from cytosol to membrane was prevented by PKC ␤ 2 siRNA knockdown cells ( fig. 9 d, e) . The ratio of membrane/cytosol p47 phox was 1.1 8 0.1, compared with the TNF-␣ -induced ratio 6.0 8 0.6. Similarly, the ratio of membrane/cytosol p67 phox was 1.1 8 0.3, compared with the TNF-␣ -induced ratio 9.6 8 1.4. All the results achieved statistical significance (p ! 0.05).
Discussion
TNF-␣ is well known to increase ROS production in the endothelium [29, 30] , the single layer of cells which lines the inner surface of all blood vessels and plays a significant role in maintaining vascular function [31] . Endothelial function appears to deteriorate in several disease states, such as hypertension, diabetes and hypercholesterolemia [32] ; such endothelial dysfunction might play a major role in the development of arteriosclerosis. Studies have shown that in neutrophils, the activation of NADPH oxidase involves the translocation and binding of cytosolic subunits such as p47 phox and p67 phox to cytochrome b 558 . The main new findings of our study are that (1) TNF-␣ could increase apoptosis via oxidative stress in HUVEC, (2) the PKC-␤ 2 pathway may play a much more important role than the PKC-␦ pathway in TNF-␣ -induced HUVEC apoptosis via ROS production and (3) ROS production is closely related with NADPH oxidase subunit upregulation, especially NOX2/gp91 phox , NOX4, p47 phox and p67 phox , but not p22 phox .
It is well known that a large family of multisubunit NADPH oxidases appears to be a predominant contributor to endothelial superoxide generation, and this enzyme can be activated by various stimuli [33] . Moreover, in human neutrophils, many protein kinase pathways have been involved in the regulation of NADPH oxidase activation, among which the PKC family seems to play an important role (upon PMA activation), and other kinases such as the JNK, ERK, MAPK and PAK may also participate in the process [34] [35] [36] [37] . Although there are also reports on PKC involvement upon NADPH oxidase activation after the TNF-␣ stimulation of cultured HU-VEC [17] , which PKC-specific isoform is involved and the precise regulation mechanism that occurs remain unknown. Our results reveal that PKC ␤ 2 isoform pathway activation is involved in superoxide formation in this context. TNF-␣ administration to HUVEC in vitro causes a substantial ROS production increase and con- PCRs for NOX2/gp91 phox , NOX4, p22 phox , p47 phox and p67 phox were performed in TNF-␣ -stimulated HUVEC in combination with pharmacological inhibitors and ratios of target gene/ ␤ -actin mRNA copies were obtained. Real-time-PCR was used to detect changes in NOX2/gp91 phox , NOX4, p22 phox , p67phox gene expression. Results are presented as fold changes compared to normal control HUVEC after normalization with ␤ -actin expression level. * p ! 0.05 40 ng/ml TNF-␣ group versus control group, $ p ! 0.05 TNF-␣ in combination with 10 M rottlerin versus 40 ng/ml TNF-␣ , d p ! 0.05 TNF-␣ in combination with 1 M CGP53353 versus 40 ng/ml TNF-␣ , P p ! 0.05 TNF-␣ in combination with 3 ! 10 -4 M apocynin versus 40 ng/ml TNF-␣ , # p 1 0.05 TNF-␣ in combination with 10 M rottlerin versus 40 ng/ml TNF-␣ , j p 1 0.05 TNF-␣ in combination with 10 M rottlerin versus TNF-␣ in combination with 1 M CGP53353. spicuous apoptosis. Treatment with both PKC ␤ 2 and PKC ␦ inhibition preserves the bioactivity of HUVEC and effectively attenuates apoptosis, whereas only PKC ␤ 2 inhibition could significantly decrease ROS formation. We may therefore infer that the PKC ␤ 2 inhibitor, but not the PKC ␦ inhibitor, plays a role in attenuating TNF-␣ -induced apoptosis via ROS production. According to our research, rottlerin is just as effective as CGP53353 in reducing TNF-␣ -induced apoptosis indicating that PKC ␦ is also required. Indeed, a combination of CGP53353 and rottlerin is even more protective than either drug alone. They may act separately. In addition, although the role of PKC ␤ 2 in TNF-␣ -induced endothelial apoptosis was demonstrated previously [20] , ECV304 cell lines are no longer considered to be human EC lines, so we chose to study primary HUVEC in our paper. Furthermore, an increase in gene expression in cytochrome b 558 could be involved in this apoptosis-induced process. Our experiments also showed that TNF-␣ induced the mobilization of NOX2/gp91 phox protein, but not p22 phox protein, to the plasma membrane is controlled by CGP53353 and rottlerin to different extents. CGP53353 inhibited NOX2/gp91 phox expression in TNF-␣ -induced apoptosis to a greater extent than rottlerin, but neither CGP53353 nor rottlerin could inhibit p22 phox expression in the apoptosis process. Thus, we presumed that gp91 phox (but not p22 phox ) of cytochrome b 558 may play an important role in TNF-␣ -induced ROS production and HU-VEC apoptosis. The level of translation and transcription are not matching, however.
To explore the molecular mechanism, we investigated the effect of 40 ng/ml TNF-␣ -induced activation on the expression of NADPH oxidase subunits, such as NOX4, p47 phox and p67 phox . We found that an addition of TNF-␣ induces a strong translocation of the cytosolic components such as p47 phox and p67 phox to plasma membrane where there is already a binding of b 558 . Subunit activation is inhibited specifically by the PKC ␤ 2 inhibitor CGP53353 and the PKC ␦ inhibitor rottlerin, to different extents. To further confirm the role of PKC ␤ 2 , we constructed cells transfected with target si-RNA. The results confirm the conclusion that PKC ␤ 2 can inhibit apoptosis and ROS induced by TNF-␣ . Moreover, it can inhibit NOX4 and NOX2/gp91 phox expression and restrain p47 phox and p67 phox translocation. All these results suggest that the molecular mechanism underlying 40 ng/ml TNF-␣ -induced NADPH oxidase activation may be via PKC ␤ 2 -dependent activation of the NADPH oxidase subunits NOX2/gp91 phox , NOX4, p47 phox and p67 phox . Based on the results of this study, despite the abundant evidence about the possible role of oxidative stress in TNF-␣ -induced endothelium dysfunction, classic antioxidants such as vitamin E have failed to exhibit definitive beneficial effects. Inhibition of oxidative stress in high TNF-␣ level-associated vascular disease by PKC isoform inhibitors strongly supports the view that inhibition of the PKC ␤ 2 -dependent activation of NADPH oxidase may be a new target for antioxidative therapy to prevent endothelium dysfunction-related vascular disease. A better understanding of the complicated mechanisms and signal transduction pathways involved in NADPH oxidase activation will permit the design and development of new therapeutic drugs to downregulate ROS generation without decreasing the normal response to harmful environmental stimuli. phox and NOX4 were detected in vector control transfectants and PKC ␤ 2 siRNA transfectants in the presence of 40 ng/ml TNF-␣ . P47 phox and p67 phox protein were also detected in both the membrane and cytosol part in the presence of 40 ng/ ml TNF-␣ . b , c Relative density of NOX4 and NOX2/gp91 phox with ␤ -actin as normalization control. d , e Western blot analysis of membrane, cytosol, ratio of membrane/cytosol p47 phox and p67 phox. ␤ -Actin was used as a loading control for the normalization of the band intensity. * p ! 0.05 versus vector control group, ** p ! 0.05 versus vector control in the presence of the 40 ng/ml TNF-␣ group.
However, it should be noted that further mechanisms should be elucidated in PKC ␤ 2 -activating NADPH oxidase. Lastly, all experiments in our study involved primary cultured HUVEC in vitro, and the results may therefore not be extrapolated to HUVEC in situ, an environment with mechanical shear stress, physiological hormones and cytokines.
Conclusion
High TNF-␣ level exposure induces HUVEC apoptosis, as well as increasing ROS generation via the PKC ␤ 2 -dependent activation of vascular NADPH oxidase. Although the PKC ␦ pathway may enhance TNF-␣ -induced HUVEC apoptosis, it does not involve the ROS pathway. Upregulation of the expression of NADPH subunits, namely NOX2/gp91 phox , NOX4, p47 phox and p67 phox , is important in this process, which is leading to a new target in antioxidative therapy for vascular disease prevention.
